CA2000508C - Dispositif de soutien pour prevenir la formation d'escarres de decubitus - Google Patents
Dispositif de soutien pour prevenir la formation d'escarres de decubitus Download PDFInfo
- Publication number
- CA2000508C CA2000508C CA 2000508 CA2000508A CA2000508C CA 2000508 C CA2000508 C CA 2000508C CA 2000508 CA2000508 CA 2000508 CA 2000508 A CA2000508 A CA 2000508A CA 2000508 C CA2000508 C CA 2000508C
- Authority
- CA
- Canada
- Prior art keywords
- cells
- support system
- inflated
- deflated
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title abstract description 21
- 230000015572 biosynthetic process Effects 0.000 title abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 41
- 239000012530 fluid Substances 0.000 claims abstract description 25
- 239000010410 layer Substances 0.000 claims description 81
- 239000007788 liquid Substances 0.000 claims description 36
- 238000010438 heat treatment Methods 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 22
- 239000004744 fabric Substances 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000002356 single layer Substances 0.000 claims description 6
- 230000004089 microcirculation Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000002572 peristaltic effect Effects 0.000 claims description 3
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 196
- 210000003491 skin Anatomy 0.000 description 15
- 238000011084 recovery Methods 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 238000009835 boiling Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010011985 Decubitus ulcer Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000005033 polyvinylidene chloride Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 208000037906 ischaemic injury Diseases 0.000 description 2
- 210000002239 ischium bone Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000000954 sacrococcygeal region Anatomy 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- OHMHBGPWCHTMQE-UHFFFAOYSA-N 2,2-dichloro-1,1,1-trifluoroethane Chemical compound FC(F)(F)C(Cl)Cl OHMHBGPWCHTMQE-UHFFFAOYSA-N 0.000 description 1
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010040030 Sensory loss Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 210000000527 greater trochanter Anatomy 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000001931 thermography Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229920005609 vinylidenefluoride/hexafluoropropylene copolymer Polymers 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Invalid Beds And Related Equipment (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2000508 CA2000508C (fr) | 1989-10-11 | 1989-10-11 | Dispositif de soutien pour prevenir la formation d'escarres de decubitus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2000508 CA2000508C (fr) | 1989-10-11 | 1989-10-11 | Dispositif de soutien pour prevenir la formation d'escarres de decubitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2000508A1 CA2000508A1 (fr) | 1991-04-11 |
| CA2000508C true CA2000508C (fr) | 2001-12-25 |
Family
ID=4143303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2000508 Expired - Fee Related CA2000508C (fr) | 1989-10-11 | 1989-10-11 | Dispositif de soutien pour prevenir la formation d'escarres de decubitus |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2000508C (fr) |
-
1989
- 1989-10-11 CA CA 2000508 patent/CA2000508C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2000508A1 (fr) | 1991-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5010608A (en) | Support system for reducing formation of decubitus ulcers | |
| US8051516B2 (en) | Clinical support pad | |
| AU2024203962B2 (en) | Patient transport apparatus and method | |
| US6210427B1 (en) | Support apparatus with a plurality of thermal zones providing localized cooling | |
| EP0364249B1 (fr) | Dispositif de support | |
| WO1996003957A1 (fr) | Coussin pneumatique pour fauteuil roulant | |
| WO2004002274A1 (fr) | Matelas | |
| EP1553908A1 (fr) | Matelas pour decubitus intelligent | |
| MXPA97006559A (en) | Support device with cooling located in areas of the surface of the body with high contact | |
| US20220040019A1 (en) | System And Methods For Supporting And Positioning A Person | |
| HK1006409B (en) | Support system | |
| WO2017023832A1 (fr) | Dispositif de rembourrage | |
| CN112188854B (zh) | 可膨胀的灌注增强装置及相关设备，系统和方法 | |
| US20050060809A1 (en) | Methods and devices for reducing stress concentration when supporting a body | |
| WO2005013878A3 (fr) | Systeme support a matelas d'air, en tant que surface servant de couchette pour patients, en particulier pour tables d'operation | |
| CA2000508C (fr) | Dispositif de soutien pour prevenir la formation d'escarres de decubitus | |
| US20080028532A1 (en) | Mattress and method for reducing stress concentration when supporting a body | |
| RU214869U1 (ru) | Противопролежневый матрац с улучшенным несущим компонентом | |
| Newell Jr et al. | The management of pressure and other external factors in the prevention of ischemic ulcers | |
| CN204379615U (zh) | 一种多体位可调控气垫床 | |
| Brienza et al. | Tissue integrity management | |
| Maylor | The rationale behind pressure-reducing equipment: 2 | |
| UK | Pressure redistributing devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |